ARDT vs SGRY Stock Comparison

Ardent Health and Surgery Partners Prices as of Nov 13, 2026 Peers: Industry group
ARDT Ardent Health, Inc.
$17.77 +48.7% 1M +91.1% 1Y
Market cap
$2.53B
P/E
17.3x
Revenue (TTM)
$6.45B
Div. yield
–
Hospitals Healthcare
7 wins
SGRY Surgery Partners, Inc.
$26.95 +81.7% 1M +76.0% 1Y
Market cap
$3.46B
P/E
–
Revenue (TTM)
$3.36B
Div. yield
–
Healthcare Services Healthcare
2 wins

Head to Head

9 decided of 12

Ardent Health leads on 7 of the 12 questions below (Ardent Health 7, Surgery Partners 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionARDTSGRYLeader
Larger companyMarket capitalisation $2.53B $3.46B SGRY
Cheaper on earningsLower P/E, profitable companies only 17.3x -39.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.3x 74.9x ARDT
Faster revenue growthRevenue growth, trailing twelve months +2.0% +2.2% SGRY
More profitableNet margin, trailing twelve months 2.3% -2.6% ARDT
Better return on capitalReturn on invested capital 9.5% 4.5% ARDT
Less leveragedLower net debt / EBITDA 0.6x 4.9x ARDT
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +91.1% +76.0% ARDT
Better 5-year returnAnnualised price return, 5 years — -12.1%/yr –
Less volatileAnnualised volatility, 1 year 49.1% 61.0% ARDT
Higher overall scoreMean of the five percentile scores vs peers 65/100 47/100 ARDT

Percentile Scorecard

ARDTSGRY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisARDTSGRY
Valuation 96 #5 of 99 75 #26 of 99
Growth 26 #66 of 89 19 #72 of 89
Profitability 74 #25 of 92 57 #40 of 92
Financial Health 63 #39 of 103 37 #65 of 103
Shareholder Returns 65 #23 of 63 –
Overall 65 47
  • ARDT ranked among 103 companies in Healthcare Providers
  • SGRY ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodARDTSGRYSPY
1 month +48.7%+81.7% -2.0%
3 months +62.7%+79.3% -2.8%
6 months +75.9%+93.2% +2.0%
Year to date +101.2%+74.4% +10.6%
1 year +91.1%+76.0% +12.2%
3 years —-10.7% +68.1%
3 years, per year —-3.7% +18.9%
5 years —-47.4% +61.4%
5 years, per year —-12.1% +10.1%
10 years —+79.1% +248.5%
10 years, per year —+6.0% +13.3%

Risk

MeasureARDTSGRYSPY
Volatility, 1Y 49.1%61.0% 13.6%
Downside volatility, 1Y 44.8%49.3% 13.9%
Beta vs S&P 500, 1Y 0.291.06 1.00
Return / volatility, 1Y 1.861.25 0.90
Max drawdown, 5Y -61.2%-81.4% -25.4%
From 52-week high -2.3%0.0% -3.2%
52-week high $18.18$26.95 $779.14
52-week low $7.83$11.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleARDTSGRY
P/E now vs peer median 17.1xmedian 22.4x -39.9xmedian 22.4x
P/S now vs peer median 0.4xmedian 1.3x 1.0xmedian 1.3x
EV/EBITDA now vs peer median 5.5xmedian 14.2x 11.3xmedian 14.2x
P/FCF now vs peer median 8.9xmedian 19.0x 17.4xmedian 19.0x
P/B now vs peer median 1.4xmedian 2.6x 1.2xmedian 2.6x
PEG now vs peer median —median 0.84 1.13median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsARDTSGRY
Revenue $6.45B $3.36B
Gross profit $5.35B $747.60M
Operating income $343.67M $363.70M
Net income $194.40M $1.70M
Free cash flow $282.30M $202.80M
EPS (diluted) $1.03 $-0.68
Cash & equivalents $766.24M $354.50M
Total debt $1.10B $3.06B
Shares (diluted) 141.70M 128.87M
Enterprise value -$280.73M $2.47B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricARDTSGRY
P/E 17.1x -39.9x
P/FCF 8.9x 17.4x
P/Operating cash flow 5.2x 12.7x
P/S 0.4x 1.0x
P/B 1.4x 1.2x
P/Tangible book 1.5x 1.2x
EV/EBITDA 5.5x 11.3x
EV/EBIT 8.3x 17.1x
EV/Revenue 0.4x 1.9x
EV/FCF 10.0x 30.7x
EV/Operating cash flow 5.9x 22.4x
PEG (3Y EPS CAGR) – 1.13

Growth

14 metrics
MetricARDTSGRY
Revenue growth (1Y) 2.0% 2.2%
Revenue CAGR (3Y) – 7.4%
Gross profit growth (1Y) 1.7% -4.9%
Gross profit CAGR (3Y) – -92.0%
Operating income growth (1Y) -17.7% -10.5%
Operating income CAGR (3Y) – 4.3%
Net income growth (1Y) -16.1% 102.2%
Net income CAGR (3Y) – -72.9%
EPS growth (1Y) -28.9% 49.9%
EPS CAGR (3Y) – -35.3%
Operating cash flow growth (1Y) 31.4% -1.6%
Operating cash flow CAGR (3Y) – 5.2%
Free cash flow growth (1Y) 79.3% 4.5%
Free cash flow CAGR (3Y) – 11.4%

Profitability

14 metrics
MetricARDTSGRY
Gross margin 82.8% 22.2%
EBITDA margin 8.0% 16.4%
Operating margin 5.3% 10.8%
Pretax margin 4.5% 2.7%
Net margin 2.3% -2.6%
FCF margin 4.4% 6.0%
Operating cash flow margin 7.5% 8.3%
Return on equity 13.1% 2.4%
Return on assets 4.3% 0.9%
Return on invested capital 9.5% 4.5%
Return on capital employed 8.0% 5.2%
Asset turnover 1.2x 0.4x
Cash conversion (OCF / net income) 2.5x 163.5x
Stock comp / revenue 0.5% 0.4%

Financial Health

11 metrics
MetricARDTSGRY
Debt / assets 20.5% 43.3%
Debt / equity 0.6x 1.1x
Net debt / EBITDA 0.6x 4.9x
Debt / FCF 3.9x 15.1x
Liabilities / assets 66.6% 58.9%
Equity / assets 33.4% 41.1%
Interest coverage 6.5x –
Current ratio 2.1x 2.2x
Quick ratio 1.4x 1.6x
Cash ratio 0.8x 0.7x
Altman Z-score 2.26 1.08

Shareholder Returns

7 metrics
MetricARDTSGRY
Dividend yield – –
Net buyback yield 0.4% –
Shareholder yield 0.4% –
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusARDTSGRY
Forward P/E 17.3xFY2026 74.9xFY2026
EPS, next fiscal year $1.03FY2026 $0.36FY2026
EPS growth, next FY +7.3%FY2026 -23.4%FY2026
EPS growth, the year after +12.6% -22.2%
Revenue, next fiscal year $6.86BFY2026 $3.31BFY2026
Revenue growth, next FY +8.5%FY2026 0.0%FY2026
Revenue growth, the year after +0.4% -7.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersARDTSGRY
Held by institutions 76.4% 100.0%
Institutions holding 137 191
Change in shares held, QoQ +1.4% -0.8%
Institutions buying 87 113
Institutions selling 36 50
Buyers to sellers 2.42 2.26

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ARDTSGRY
ARDT 1.00 0.21
SGRY 0.21 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ARDT and SGRY?

Surgery Partners (SGRY) is the largest by market capitalisation: Ardent Health (ARDT) $2.53B, Surgery Partners (SGRY) $3.46B.

Which company is growing faster?

Surgery Partners (SGRY) grew revenue fastest over the trailing twelve months: Ardent Health (ARDT) +2.0%, Surgery Partners (SGRY) +2.2%.

Which company is more profitable?

Ardent Health (ARDT) has the highest net margin (Ardent Health (ARDT) 2.3%, Surgery Partners (SGRY) -2.6%). On return on invested capital, Ardent Health (ARDT) leads (Ardent Health (ARDT) 9.5%, Surgery Partners (SGRY) 4.5%).

Which stock has performed better?

Over the past year Ardent Health (ARDT) returned the most: Ardent Health (ARDT) +91.1%, Surgery Partners (SGRY) +76.0%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ardent Health (ARDT) has been the steadiest (Ardent Health (ARDT) 49.1%, Surgery Partners (SGRY) 61.0%). Volatility measures how widely the price swings, not the risk of the business.

Do ARDT and SGRY move together?

Their daily returns over the past year have a correlation of 0.21, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, ARDT and SGRY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Ardent Health (ARDT) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.